Epicardial halo phenomenon: a guide for pericardiocentesis?
The epicardial halo delineates the heart shadow in fluoroscopy. To establish whether the sign is applicable to pericardiocentesis guidance, three investigators evaluated its intensity as absent = grade 0, indistinct = 0.5, clear = 1, intensive = 2 in posterior-anterior (PA) and lateral fluoroscopies recorded before pericardiocentesis or cardiac catheterization (Philips Integris-II BH3000). Three populations were studied: (a) 32 patients with pericardial effusion (PE group), 53.1 % males, aged 53.9 ± 13.9 years; (b) 14 patients with perimyocarditis (PM group), 64.3 % males, aged 51.6 ± 14.4 years; and (c) 46 coronary patients (CAD group), no PE, 95.6 % males, aged 67.3 ± 11.8 years. The intensity of the halo phenomenon was highest in patients with PE, lowest in patients with CAD, and intermediate in patients with PM (median sum of grades in PA/lateral view: 4/5 vs. 2/2.5 vs. 3/3, respectively) (p < 0.01). The halo phenomenon correlated well with HR and echocardiographic PE size in both angiographic views. The correlation with body mass index (BMI) and age was significant only in the lateral view and with PE volume only in the PA view. The sensitivity of the halo sign for PE was 84.1 % in PA and 92.0 % in lateral views. In 10/32 PE patients, the evaluation of the sign was repeated after PE drainage, revealing lower grades both in PA and in lateral views (p < 0.01). In conclusion, the epicardial halo sign is highly sensitive for the detection of a PE; it correlates well in at least one angiographic projection with the PE volume, HR, age, BMI, and the PE size in echocardiography and could be therefore applied as a safety guide for pericardiocentesis.
Department of Cardiology, Belgrade University School of Medicine and Clinical Center of Serbia, Koste Todorovića 8, 11000, Belgrade, Serbia. arsen.ristic@med.bg.ac.rs
Arsen D
AD
Ristić
Hans-Joachim
HJ
Wagner
Ružica
R
Maksimović
Bernhard
B
Maisch
D000273:Adipose Tissue / Q000473:pathology; D000328:Adult; D000367:Age Factors; D000368:Aged; D015992:Body Mass Index; D006328:Cardiac Catheterization / Q000379:methods; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000503:physiopathology; D004452:Echocardiography / Q000379:methods; D005260:Female; D005471:Fluoroscopy / Q000379:methods / Q000706:statistics & numerical data; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D010490:Pericardial Effusion / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D020519:Pericardiocentesis / Q000379:methods*; D010493:Pericarditis / Q000209:etiology / Q000503:physiopathology; D010496:Pericardium / Q000000981:diagnostic imaging* / Q000473:pathology; D012680:Sensitivity and Specificity; D016896:Treatment Outcome